CareLit · DOI-Nachweis · Geburtshilfe und Frauenheilkunde
LIBERATE trial: A safety study of tibolone in breast cancer patients–design and baseline data
DOI 10.1055/s-2006-952500
Bibliografische Angaben
Nachweis in CareLit
Autor:innenMW Beckmann, JM Foidart, NJ Bundred, P Kenemans, E Kubista, B v. Schoultz, P Sismondi, P Sismondi, R Vassilopoulou-Sellin, CH Yip, R Kimmig
ZeitschriftGeburtshilfe und Frauenheilkunde
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background/Objectives: Hormone therapy is contraindicated in women with a history of breast cancer. A pilot study has shown that tibolone relieves vasomotor symptoms in patients receiving tamoxifen after breast cancer surgery. Studies have also shown that tibolone does not stimulate breast tissue, prevents osteoporosis and might therefore be a promising agent to treat vasomotor symptoms in these women. LIBERATE was…
Zitieren
Zitierempfehlung
MW Beckmann, JM Foidart, NJ Bundred, P Kenemans, E Kubista, B v. Schoultz, P Sismondi, P Sismondi, R Vassilopoulou-Sellin, CH Yip, R Kimmig (2006) LIBERATE trial: A safety study of tibolone in breast cancer patients–design and baseline data. Geburtshilfe und Frauenheilkunde (09). https://doi.org/10.1055/s-2006-952500
Mit CareLit weiterarbeiten